Gastroenterology
Volume 124, Issue 4 , Page 889, April 2003

Ursodeoxycholic acid reduces the risk of developing colorectal cancer in patients with ulcerative colitis and sclerosing cholangitis

No abstract is available. To read the body of this article, please view the Full Text online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0016-5085(03)70055-9

Refers to article:

  • Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis

    Darrell S. Pardi, Edward V. Loftus, Walter K. Kremers, Jill Keach, Keith D. Lindor
    Gastroenterology April 2003 (Vol. 124, Issue 4, Pages 889-893)

Gastroenterology
Volume 124, Issue 4 , Page 889, April 2003

Article Tools

* Image Usage & Resolution